Anthony Japour's most recent trade in Cocrystal Pharma Inc was a trade of 14,924 Common Stock done . Disclosure was reported to the exchange on Oct. 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cocrystal Pharma Inc | Anthony Japour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 14,924 | 14,924 (0%) | 0% | - | Common Stock | |
Cocrystal Pharma Inc | Anthony Japour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 13,567 | 13,567 | - | - | Stock Options (Right to Buy) | |
Cocrystal Pharma Inc | Anthony Japour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 148,000 | 148,000 | - | - | Stock Options (Right to Buy) | |
Cocrystal Pharma Inc | Anthony Japour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 74,000 | 74,000 | - | - | Stock Options (Right to Buy) | |
Cocrystal Pharma Inc | Anthony Japour | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 56,000 | 56,000 | - | - | Stock Options (Right to Buy) |